Distinguished in Neuroendocrine Tumor

Ming F. Lu

Key Laboratory Of Carcinogenesis And Translational Research, 
Beijing, CN 
Distinguished in Neuroendocrine Tumor
Key Laboratory Of Carcinogenesis And Translational Research, 
Beijing, CN 
OverviewLocationsClinical Research

Overview

Ming Lu practices in Beijing, China. Lu is rated as a Distinguished expert by MediFind in the treatment of Neuroendocrine Tumor. Their top areas of expertise are Neuroendocrine Tumor, Stomach Cancer, Spinal and Bulbar Muscular Atrophy, Colonoscopy, and Hemorrhoidectomy.

Their clinical research consists of co-authoring 383 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 32 articles in the study of Neuroendocrine Tumor.

Locations

Key Laboratory Of Carcinogenesis And Translational Research, Beijing, China
Other Locations
No.199 Donggang West Road, Lanzhou, 730000, China
No.215 Heping West Road, Shijiazhuang, 050000, China
No. 49 Huayuan North Road, Huayuan, 100191, China
#218 Ji Xi Road, Hefei, 230032, China
NO.358, Datong Road, Pudong, 200137, China
Fuxing Road 28, Beijing, 100853, China
121, Jiangjiayuan Road, Nanjing, 210011, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Combination Treatment of S-1 With Paclitaxel Versus Paclitaxel+Cisplatin and 5-Fu+Cisplatin as First-line Treatment in Advanced Esophageal Cancer
Combination Treatment of S-1 With Paclitaxel Versus Paclitaxel+Cisplatin and 5-Fu+Cisplatin as First-line Treatment in Advanced Esophageal Cancer
Enrollment Status: Terminated
Publish Date: April 07, 2017
Intervention Type: Drug
Study Phase: Phase 2/Phase 3

381 Total Publications

Segmentation of Glioma Sub-regions Based on EnnUnet in Tumor Treating Fields.
Segmentation of Glioma Sub-regions Based on EnnUnet in Tumor Treating Fields.
Journal: Biomedical physics & engineering express
Published: October 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Lu's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 92 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile